Amphetamine toxicity

Seminars in Respiratory and Critical Care Medicine

Volumn 23, Issue 1, 2002, Pages 27-36

  White, Suzanne R ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Amphetamine; Ecstasy; Ephedra; Ephedrine; Ma Huang; MDMA; Methamphetamine

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 BROMO 2,5 METHOXYPHENYLETHYLAMINE; 4 METHOXYAMPHETAMINE; 4 METHYL 2,5 DIMETHOXYAMPHETAMINE; AMPHETAMINE; AMPHETAMINE DERIVATIVE; BROLAMFETAMINE; EPHEDRA EXTRACT; EPHEDRINE; METHAMPHETAMINE; UNCLASSIFIED DRUG;

ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CHRONICITY; COOLING; DISEASE ASSOCIATION; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DOPAMINERGIC NERVE CELL; DRUG ABUSE; DRUG OVERDOSE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERPYREXIA; HYPERTHERMIA; HYPONATREMIA; KIDNEY FAILURE; LIVER NECROSIS; NERVE CELL LESION; NEUROPSYCHIATRY; NEUROTOXICITY; PRIORITY JOURNAL; RHABDOMYOLYSIS; RISK ASSESSMENT; SEDATION; SEROTONINERGIC NERVE CELL; TOXICITY TESTING; VASCULITIS;

EID: 0036186118     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-20586     Document Type: Article

References (103)

1. Effect of benzedrine sulfate on mood and fatigue in normal and neurotic persons
2. Update on methamphetamine abuse
3. The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenrative processes
4. MDMA (ecstasy) inhibition of MAO type A and type B: Comparisons with fenfluramine and fluoxetine (Prozac)
5. Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor Citalopram
6. Fatal amphetamine poisoning
7. Ecstasy intoxication: An overlap between serotonin syndrome and neuroleptic malignant syndrome
8. Seven years of 3,4-methylenedioxymethamphetamine (MDMA) toxicity
9. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids
10. Sudden death of a healthy college student related to ephedrine toxicity from a Ma Huang-containing drink
11. Adverse events associated with ephedrine - Containing products - Texas, December 1993 - September 1995
12. Fatal ephedrine intoxication
13. Dilated cardiomyopathy in a heavy ephedrine abuser
14. Cardiovascular toxicity after ingestion of "herbal ecstacy"
15. Stroke associated with ephedrine use
16. Ephedrine psychosis
17. Ephedrine-induced mania from an herbal diet supplement
18. Intracerebral hemorrhage and vasculitis related to ephedrine abuse
19. Averse events with Ephedra other botanical dietary supplements
20. Ma-Huang strikes again: Ephedrine nephrolithiasis
21. Erythroderma associated with ingestion of an herbal product
22. Acute hepatitis associated with the use of a chinese herbal product, Ma Huang
23. A review of the botany, chemistry, medicinal uses, safety concerns, and legal status of ephedra and its alkaloids
24. Hyperpyrexia induced by 3,4-methylenedioxymethamphetamine ("Ecstasy")
25. Survival following "Ecstasy" ingestion with a peak temperature of 42°C
26. Inadvertent methamphetamine poisoning in pediatric patients
27. Lethal monointoxication by overdosage of MDEA
28. Ecstasy and the anaesthetist
29. The hyperthermic and neurotoxic effects of ecstasy (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype
30. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans
31. Psychological and cardiovascular effects and short-term sequelae of MDMA ("Ecstasy") in MDMA-naïve healthy volunteers
32. Recreational drug misuse: Issues for the cardiologist
33. Acute aortic dissection and ruptured berry aneurysms associated with methamphetamine abuse
34. Methamphetamine overdose: Experience with six cases
35. Myocardial infarction after inhalation of methamphetamine
36. Acute myocardial infarction resulting from amphetamine abuse: Spasm thrombus interplay?
37. Necrotising angiitis associated with drug abuse
38. Cardiomyopathy associated with the smoking of crystal methamphetamine
39. Methamphetamine-related stroke: Four cases
40. Ephedrine-related stroke in a teenager
41. Emergence of recreational drug abuse as a major risk factor for stroke in young adults
42. Cerebral vasculitis associated with oral amphetamine overdose
43. Amphetamine abuse and intracranial haemorrhage
44. Ischemic stroke associated with methamphetamine inhalation
45. Acute inflammatory CNS disease after MDMA ("Ecstasy")
46. Parkinsonism after taking ecstasy
47. Infant methamphetamine toxicity posing as scorpion envenomation
48. Choreoathetoid disorders associated with amphetamine-like drugs
49. The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system
50. Memory deficits associated with recreational use of "Ecstasy" (MDMA)
51. Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") users: A controlled study
52. Memory impairment in abstinent MDMA ("Ecstasy") users
53. Long-term psychiatric and cognitive effects of MDMA use
54. Does recreational ecstasy use cause long-term cognitive problems?
55. Ecstasy (MDMA) dependence
56. Reorganization of ascending 5-HT axon projections in animals previously exposed to recreational drug (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy")
57. Toxic effects of MDMA on central serotonergic neurons in the primate: Importance of route and frequency of drug administration
58. (+/-) 3,4-methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates
59. Lasting effects of (+/-) 3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: Neurochemical observations
60. Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: Factors influencing abnormal recovery
61. Molecular footprints of neurotoxic amphetamine action
62. Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers
63. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain
64. Repeated exposure to methylenedioxymethamphetamine(MDMA) alters nucleus accumbens neuronal responses to dopamine and serotonin
65. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings
66. Striatal serotonin is depleted in brain of a human MDMA (ecstasy) user
67. Ecstasy long-term effects on the human central nervous system revealed by positron emission tomography
68. Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: A co-registered SPECT and MRI study
69. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission
70. Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study
71. Is a single dose of MDMA harmless?
72. Hyponatraemia and seizures after ecstasy use
73. Near fatal hyponatraemic coma due to vasopressin oversecretion after "Ecstasy" 3,4-methylenedioxymethamphetamine (MDMA)
74. Hyponatraemia after ingestion of "Ecstasy."
75. Hyponatraemla and death after "Ecstasy" ingestion
76. Inappropriate antidiuretic hormone secretion and extreme rises in serum creatine kinase following MDMA ingestion
77. Low dose MDMA ("Ecstasy") induces vasopressin secretion
78. Severe hyponatremia and inappropriate antidiuretic hormone secretion following ecstasy use
79. Death from hyponatraemia-induced cerebral oedema associated with MDMA ("Ecstasy") use
80. Metabolic consequences of drug misuse
81. Stimulant-induced pulmonary toxicity
82. Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine: A systematic review of the evidence
83. Chest pain in a young girl
84. Hepatotoxicity of psychotropic drugs
85. Ecstasy: A common cause of severe acute hepatotoxicity
86. Acute liver damage and ecstasy ingestion
87. Case records of the Massachusetts General Hospital
88. Chronic ecstasy (3,4-methylenedioxymethamphetamine) abuse: A recurrent and unpredictable cause of severe acute hepatitis
89. Methamphetamine-induced ischemic colitis
90. Association of cocaine and methamphetamine use with giant gastroduodenal ulcers
91. Methamphetamine abuse and rhabdomyolysis in the ED: A 5-year study
92. Creatine kinase isoform changes following ecstasy overdose
93. Ecstasy: Creatinine kinase
94. Amphetamine-induced acute renal failure
95. Ecstasy-induced renal vasculitis
96. Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetamine ("Ecstasy")
97. Ineffectiveness of dantrolene sodium in the treatment of heatsroke
98. Protection against damphetamine toxicity
99. Chemical restraint for the agitated patient in the emergency department: Lorazepam versus droperidol
100. MDMA induced hyperthermia: Report of a fatality and review of current therapy
101. Review article: Mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications